Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1087-1094
doi: 10.1161/ATVBAHA.0000261548.49790.63
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Freedman, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Freedman, N. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1087.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis

Lisheng Zhang; Karsten Peppel; Perumal Sivashanmugam; Eric S. Orman; Leigh Brian; Sabrina T. Exum; Neil J. Freedman

From Duke University Departments of Medicine (Cardiology) and Cell Biology, Duke University Medical Center, Durham, NC. Current address for K.P.: Jefferson University Center for Translational Medicine, 1025 Walnut St, Philadelphia, PA 19107.

Correspondence to Neil J. Freedman or Karsten Peppel, Box 3187, Duke University Medical Center, Durham, NC 27710. E-mail neil.freedman{at}duke.edu or karsten.peppel@jefferson.edu

Objective— Mechanisms by which tumor necrosis factor-{alpha} (TNF) contributes to atherosclerosis remain largely obscure. We therefore sought to determine the role of the arterial wall TNF receptor-1 (TNFR1) in atherogenesis.

Methods and Results— Carotid artery-to-carotid artery interposition grafting was performed with tnfr1–/– and congenic (C57Bl/6) wild-type (WT) mice as graft donors, and congenic chow-fed apolipoprotein E-deficient mice as recipients. Advanced atherosclerotic graft lesions developed within 8 weeks, and had 2-fold greater area in WT than in tnfr1–/– grafts. While the prevalence of specific atheroma cells was equivalent in WT and tnfr1–/– grafts, the overall abundance of cells was substantially greater in WT grafts. WT grafts demonstrated greater MCP-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression at both early and late time points, and proliferating cell nuclear antigen expression at early time points. Aortic atherosclerosis was also reduced in 14-month-old apoe–/–/tnfr1–/– mice, as compared with cognate apoe–/– mice. In coculture with activated macrophages, smooth muscle cells expressing the TNFR1 demonstrated enhanced migration and reduced scavenger receptor activity.

Conclusions— TNFR1 signaling, just in arterial wall cells, contributes to the pathogenesis of atherosclerosis by enhancing arterial wall chemokine and adhesion molecule expression, as well as by augmenting medial smooth muscle cell proliferation and migration.

In carotid arterial grafts implanted into apolipoprotein E-deficient mice, TNF receptor-1 deficiency reduced atherosclerotic lesion size by 2-fold. This reduction in atherosclerosis correlated with reduced arterial wall expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and MCP-1, and reduced medial SMC proliferation. TNFR1 deficiency also reduced SMC migration toward activated macrophages.


Key Words: atherosclerosis • inflammation • mouse models • smooth muscle cells • tumor necrosis factor




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Xanthoulea, M. J.J. Gijbels, I. van der Made, H. Mujcic, M. Thelen, M. N. Vergouwe, M. H.C. Ambagts, M. H. Hofker, and M. P.J. de Winther
p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice
Cardiovasc Res, November 1, 2008; 80(2): 309 - 318.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Kavurma, N. Y. Tan, and M. R. Bennett
Death Receptors and Their Ligands in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1694 - 1702.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kleemann, S. Zadelaar, and T. Kooistra
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Cardiovasc Res, August 1, 2008; 79(3): 360 - 376.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kim, L. Zhang, K. Peppel, J.-H. Wu, D. A. Zidar, L. Brian, S. M. DeWire, S. T. Exum, R. J. Lefkowitz, and N. J. Freedman
{beta}-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration
Circ. Res., July 3, 2008; 103(1): 70 - 79.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, P. Sivashanmugam, J.-H. Wu, L. Brian, S. T. Exum, N. J. Freedman, and K. Peppel
Tumor Necrosis Factor Receptor-2 Signaling Attenuates Vein Graft Neointima Formation by Promoting Endothelial Recovery
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 284 - 289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. C. Dupasquier, E. Dibrov, A. L. Kneesh, P. K. M. Cheung, K. G. Y. Lee, H. K. Alexander, B. K. Yeganeh, M. H. Moghadasian, and G. N. Pierce
Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2394 - H2402.
[Abstract] [Full Text] [PDF]